Literature DB >> 8443896

Progressive left ventricular dysfunction and remodeling after myocardial infarction. Potential mechanisms and early predictors.

P Gaudron1, C Eilles, I Kugler, G Ertl.   

Abstract

BACKGROUND: Left ventricular enlargement and the development of chronic heart failure are potent predictors of survival in patients after myocardial infarction. Prospective studies relating progressive ventricular enlargement in individual patients to global and regional cardiac dysfunction and the onset of late chronic heart failure are not available. It was the aim of this study to define the relation between left ventricular dilatation and global and regional cardiac dysfunction and to identify early predictors of enlargement and chronic heart failure in patients after myocardial infarction. METHODS AND
RESULTS: Left ventricular volumes, regional area shrinkage fraction in 18 predefined sectors (gated single photon emission computed tomography), global ejection fraction, and hemodynamics at rest and during exercise (supine bicycle, 50 W, 4 minutes, Swan-Ganz catheter) were assessed prospectively 4 days, 4 weeks, 6 months, and 1.5 and 3 years after first myocardial infarction. Seventy patients were assigned to groups with progressive, limited, or no dilatation. Patients without dilatation (n = 38) maintained normal volumes and hemodynamics until 3 years. With limited dilatation (n = 18), left ventricular volume increased up to 4 weeks after infarction and stabilized thereafter; depressed stroke volume was restored 4 weeks after infarction and then remained stable at rest. Wedge pressure during exercise, however, progressively increased. With progressive dilatation (n = 14), depressed cardiac and stroke indexes were also restored by 4 weeks but progressively deteriorated thereafter. Area shrinkage fraction as an estimate of regional left ventricular function in normokinetic sectors at 4 days gradually deteriorated during 3 years, but hypokinetic and dyskinetic sectors remained unchanged. Global ejection fraction fell after 1.5 years, whereas right atrial pressure, wedge pressure, and systemic vascular resistance increased. By multivariate analysis, ejection fraction and stroke index at 4 days, ventriculographic infarct size, infarct location, and Thrombolysis in Myocardial Infarction trial grade of infarct artery perfusion were significant predictors of progressive ventricular enlargement and chronic dysfunction.
CONCLUSIONS: Almost 26% of patients may develop limited left ventricular dilatation within 4 weeks after first infarction, which helps to restore cardiac index and stroke index at rest and to preserve exercise performance and therefore remains compensatory. A somewhat smaller group (20%) develops progressive structural left ventricular dilatation, which is compensatory at first, then progresses to noncompensatory dilatation, and finally results in severe global left ventricular dysfunction. In these patients, depression of global ejection fraction probably results from impairment of function of initially normally contracting myocardium. Early predictors from multivariate analysis allow identification of patients at high risk for progressive left ventricular dilatation and chronic ventricular dysfunction within 4 weeks after acute infarction.

Entities:  

Mesh:

Year:  1993        PMID: 8443896     DOI: 10.1161/01.cir.87.3.755

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  140 in total

Review 1.  Advances in the medical management of acute coronary syndromes.

Authors:  C P Cannon
Journal:  J Thromb Thrombolysis       Date:  1999-04       Impact factor: 2.300

Review 2.  The endoventricular circular patch plasty ("Dor procedure") in ischemic akinetic dilated ventricles.

Authors:  V Dor
Journal:  Heart Fail Rev       Date:  2001-09       Impact factor: 4.214

3.  Ventricular dilatation in the absence of ACE inhibitors: influence of haemodynamic and neurohormonal variables following myocardial infarction.

Authors:  J T Walsh; P D Batin; M Hawkins; D McEntegart; A J Cowley
Journal:  Heart       Date:  1999-01       Impact factor: 5.994

4.  Extracellular volume imaging by magnetic resonance imaging provides insights into overt and sub-clinical myocardial pathology.

Authors:  Martin Ugander; Abiola J Oki; Li-Yueh Hsu; Peter Kellman; Andreas Greiser; Anthony H Aletras; Christopher T Sibley; Marcus Y Chen; W Patricia Bandettini; Andrew E Arai
Journal:  Eur Heart J       Date:  2012-01-24       Impact factor: 29.983

Review 5.  Cardiac imaging to identify patients at risk for developing heart failure after myocardial infarction.

Authors:  Clerio F Azevedo; Susan Cheng; João A C Lima
Journal:  Curr Heart Fail Rep       Date:  2005-12

Review 6.  Surgical aspects of congestive heart failure.

Authors:  Daniel J Goldstein; Douglas Smego; Robert E Michler
Journal:  Heart Fail Rev       Date:  2006-06       Impact factor: 4.214

7.  Predictors of left ventricular dilatation in young adults (from the Bogalusa Heart Study).

Authors:  Showkat A Haji; Rifat Eralp Ulusoy; Dharmendrakumar A Patel; Sathanur R Srinivasan; Wei Chen; Patrice Delafontaine; Gerald S Berenson
Journal:  Am J Cardiol       Date:  2006-09-07       Impact factor: 2.778

8.  Three-dimension structure of ventricular myocardial fibers after myocardial infarction.

Authors:  Changqing Gao; Weihua Ye; Libin Li
Journal:  J Cardiothorac Surg       Date:  2010-11-23       Impact factor: 1.637

9.  It takes two to tango: monocyte and macrophage duality in the infarcted heart.

Authors:  Sumanth D Prabhu
Journal:  Circ Res       Date:  2014-05-09       Impact factor: 17.367

10.  A Retinoic Acid β2-Receptor Agonist Exerts Cardioprotective Effects.

Authors:  Alice Marino; Takuya Sakamoto; Xiao-Han Tang; Lorraine J Gudas; Roberto Levi
Journal:  J Pharmacol Exp Ther       Date:  2018-06-15       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.